Clinical Trial Update: Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing tacrolimus as a secondary intervention to continuing cyclosporine in renal transplant patients with chronic renal allograft f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Allograft Failure
• Renal Transplantation

Drugs mentioned

• Prograf (Tacrolimus)
• SANDIMMUNE (CYCLOSPORINE)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Renal Transplantation, Chronic Renal Allograft Failure | Phase 4 | Status: COMPLETED